From: Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma
Factors | CD8 | CD4 | T-bet | CD68 | CD57 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low | High | P-Value | Low | High | P-Value | Low | High | P-Value | Low | High | P-Value | Low | High | P-Value | |
Age | |||||||||||||||
  < 60 | 18 | 17 | 0.981 | 17 | 18 | 0.821 | 21 | 14 | 0.046* | 21 | 14 | 0.238 | 23 | 12 | 0.137 |
  ≥ 60 | 22 | 21 |  | 22 | 21 |  | 16 | 27 |  | 20 | 23 |  | 21 | 22 | |
Gender | |||||||||||||||
 Male | 31 | 27 | 0.517 | 29 | 29 | 1 | 28 | 30 | 0.802 | 30 | 28 | 0.802 | 32 | 26 | 0.709 |
 Female | 9 | 11 |  | 10 | 10 |  | 9 | 11 |  | 11 | 9 |  | 12 | 8 | |
Smoking | |||||||||||||||
 Yes | 27 | 21 | 0.27 | 25 | 23 | 0.644 | 23 | 25 | 0.915 | 24 | 24 | 0.569 | 28 | 20 | 0.667 |
 No | 13 | 17 |  | 14 | 16 |  | 14 | 16 |  | 17 | 13 |  | 16 | 14 | |
Drinking | |||||||||||||||
 Yes | 27 | 15 | 0.014* | 23 | 19 | 0.367 | 21 | 21 | 0.626 | 24 | 18 | 0.385 | 26 | 16 | 0.294 |
 No | 13 | 23 |  | 16 | 20 |  | 16 | 20 |  | 17 | 19 |  | 18 | 18 | |
Differentiation | |||||||||||||||
 Well | 26 | 31 | 0.101 | 31 | 26 | 0.205 | 27 | 30 | 0.984 | 28 | 29 | 0.319 | 32 | 25 | 0.937 |
 Moderate or Poor | 14 | 7 |  | 8 | 13 |  | 10 | 11 |  | 13 | 8 |  | 12 | 9 | |
T stage | |||||||||||||||
 T1 and T2 | 29 | 29 | 0.702 | 29 | 29 | 1 | 26 | 32 | 0.435 | 28 | 30 | 0.199 | 30 | 28 | 0.158 |
 T3 and T4 | 11 | 9 |  | 10 | 10 |  | 11 | 9 |  | 13 | 7 |  | 14 | 6 | |
N stage | |||||||||||||||
 N0 | 20 | 28 | 0.033* | 23 | 25 | 0.644 | 22 | 26 | 0.722 | 24 | 24 | 0.569 | 21 | 27 | 0.005* |
 N1-N3 | 20 | 10 |  | 16 | 14 |  | 15 | 15 |  | 17 | 13 |  | 23 | 7 | |
Clinical stage | |||||||||||||||
 I and II | 16 | 20 | 0.266 | 18 | 18 | 1 | 15 | 21 | 0.348 | 16 | 20 | 0.186 | 15 | 21 | 0.016* |
 III and IV | 24 | 18 |  | 21 | 21 |  | 22 | 20 |  | 25 | 17 |  | 29 | 13 |